Ethanol Exposure During Either Adolescence or Adulthood Alters the Rewarding Effects of Cocaine in Adult Rats
Overview
Pharmacology
Psychology
Social Sciences
Authors
Affiliations
Objectives: The present studies assessed the effects of adolescent and adult ethanol exposure on the rewarding effects of cocaine as measured with the conditioned place preference procedure.
Methods: Male rats were exposed to intraperitoneal (IP) injections of ethanol or vehicle for 10 days [postnatal days (PNDs) 30-39 or PNDs 70-79; 2 mg/kg]. Place preference conditioning began on PND 65 or PND 105, respectively, and consisted of a baseline test followed by four conditioning cycles with either 0, 5, 10 or 20 mg/kg cocaine. Following the fourth conditioning cycle a final preference test was performed. Changes in time on the drug-paired side between the baseline and final test were analyzed.
Results: Animals exposed to vehicle (during adolescence or adulthood) showed a significant place preference at 20 mg/kg cocaine. Animals exposed to ethanol (during adolescence or adulthood) showed a significant place preference at 10mg/kg cocaine.
Conclusions: Exposure to ethanol (adolescents or adults) sensitized the rewarding effects of cocaine. This may indicate an increase in the abuse liability of cocaine following a history of ethanol exposure.
Colom-Rocha C, Bis-Humbert C, Garcia-Fuster M Front Pharmacol. 2024; 15:1448170.
PMID: 39257392 PMC: 11384591. DOI: 10.3389/fphar.2024.1448170.
Nelson K, Manke H, Bailey J, Vlachos A, Maradiaga K, Huang S Pharmacol Biochem Behav. 2021; 211:173286.
PMID: 34634300 PMC: 8643339. DOI: 10.1016/j.pbb.2021.173286.
One Is Not Enough: Understanding and Modeling Polysubstance Use.
Crummy E, ONeal T, Baskin B, Ferguson S Front Neurosci. 2020; 14:569.
PMID: 32612502 PMC: 7309369. DOI: 10.3389/fnins.2020.00569.
Gerb S, Cook J, Gochenauer A, Young C, Fulton L, Grady A Comp Med. 2019; 69(1):29-34.
PMID: 30696519 PMC: 6382050. DOI: 10.30802/AALAS-CM-18-000053.
Fredriksson I, Adhikary S, Steensland P, Vendruscolo L, Bonci A, Shaham Y Neuropsychopharmacology. 2016; 42(5):1001-1011.
PMID: 27649640 PMC: 5506787. DOI: 10.1038/npp.2016.209.